BL

Blair T. Lapointe

Merck: 6 patents #47 of 1,208Top 4%
LY Lycera: 3 patents #6 of 26Top 25%
Overall (2017): #23,031 of 506,227Top 5%
6
Patents 2017

Issued Patents 2017

Patent #TitleCo-InventorsDate
9809561 Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease Thomas D. Aicher, Chad A. VanHuis, William D. Thomas, John MacLean, Brian M. Andresen +9 more 2017-11-07
9745265 4-heteroaryl substituted benzoic acid compounds as RORgammaT inhibitors and uses thereof Kenneth J. Barr, Corey E. Bienstock, John MacLean, Hongjun Zhang, Richard Thomas Beresis +3 more 2017-08-29
9663502 2-Acylamidomethyl and sulfonylamidomethyl benzoxazine carbamates for inhibition of RORgamma activity and the treatment of disease Thomas D. Aicher, Chad A. VanHuis, John MacLean, Brian M. Andresen, Kenneth J. Barr +9 more 2017-05-30
9663522 3-aminocycloalkyl compounds as RORgammaT inhibitors and uses thereof Kenneth J. Barr, John MacLean, Hongjun Zhang, Richard Thomas Beresis, Neville J. Anthony +2 more 2017-05-30
9657033 Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORγ activity and the treatment of disease Thomas D. Aicher, Kenneth J. Barr, Vladimir Simov, Karin Ann Stein, William D. Thomas +3 more 2017-05-23
9556168 N-alkylated indole and indazole compounds as RORgammaT inhibitors and uses thereof Kenneth J. Barr, Corey E. Bienstock, John MacLean, Hongjun Zhang, Richard Thomas Beresis +2 more 2017-01-31